38358083|t|Homocysteine potentiates amyloid  beta $$  upbeta $$  -induced death receptor 4- and 5-mediated cerebral endothelial cell apoptosis, blood brain barrier dysfunction and angiogenic impairment.
38358083|a|Cerebrovascular dysfunction has been implicated as a major contributor to Alzheimer's Disease (AD) pathology, with cerebral endothelial cell (cEC) stress promoting ischemia, cerebral-blood flow impairments and blood-brain barrier (BBB) permeability. Recent evidence suggests that cardiovascular (CV)/cerebrovascular risk factors, including hyperhomocysteinemia (Hhcy), exacerbate AD pathology and risk. Yet, the underlying molecular mechanisms for this interaction remain unclear. Our lab has demonstrated that amyloid beta 40 (Abeta40) species, and particularly Abeta40-E22Q (AbetaQ22; vasculotropic Dutch mutant), promote death receptor 4 and 5 (DR4/DR5)-mediated apoptosis in human cECs, barrier permeability, and angiogenic impairment. Previous studies show that Hhcy also induces EC dysfunction, but it remains unknown whether Abeta and homocysteine function through common molecular mechanisms. We tested the hypotheses that Hhcy exacerbates Abeta-induced cEC DR4/5-mediated apoptosis, barrier dysfunction, and angiogenesis defects. This study was the first to demonstrate that Hhcy specifically potentiates AbetaQ22-mediated activation of the DR4/5-mediated extrinsic apoptotic pathway in cECs, including DR4/5 expression, caspase 8/9/3 activation, cytochrome-c release and DNA fragmentation. Additionally, we revealed that Hhcy intensifies the deregulation of the same cEC junction proteins mediated by Abeta, precipitating BBB permeability. Furthermore, Hhcy and AbetaQ22, impairing VEGF-A/VEGFR2 signaling and VEGFR2 endosomal trafficking, additively decrease cEC angiogenic capabilities. Overall, these results show that the presence of the CV risk factor Hhcy exacerbates Abeta-induced cEC apoptosis, barrier dysfunction, and angiogenic impairment. This study reveals specific mechanisms through which amyloidosis and Hhcy jointly operate to produce brain EC dysfunction and death, highlighting new potential molecular targets against vascular pathology in comorbid AD/CAA and Hhcy conditions.
38358083	0	12	Homocysteine	Chemical	MESH:D006710
38358083	25	38	amyloid  beta	Gene	351
38358083	169	190	angiogenic impairment	Disease	MESH:D060825
38358083	192	219	Cerebrovascular dysfunction	Disease	MESH:D002561
38358083	266	285	Alzheimer's Disease	Disease	MESH:D000544
38358083	287	289	AD	Disease	MESH:D000544
38358083	356	364	ischemia	Disease	MESH:D007511
38358083	532	552	hyperhomocysteinemia	Disease	MESH:D020138
38358083	554	558	Hhcy	Disease	MESH:D020138
38358083	572	574	AD	Disease	MESH:D000544
38358083	763	767	E22Q	ProteinMutation	tmVar:p|SUB|E|22|Q;HGVS:p.E22Q;VariantGroup:0;CorrespondingGene:3126;CorrespondingSpecies:9606
38358083	840	843	DR4	Gene	3126
38358083	844	847	DR5	Gene	8795
38358083	871	876	human	Species	9606
38358083	909	930	angiogenic impairment	Disease	MESH:D060825
38358083	959	963	Hhcy	Disease	MESH:D020138
38358083	977	991	EC dysfunction	Disease	MESH:D006331
38358083	1024	1029	Abeta	Gene	351
38358083	1034	1046	homocysteine	Chemical	MESH:D006710
38358083	1123	1127	Hhcy	Disease	MESH:D020138
38358083	1140	1145	Abeta	Gene	351
38358083	1276	1280	Hhcy	Disease	MESH:D020138
38358083	1306	1314	AbetaQ22	Chemical	-
38358083	1448	1460	cytochrome-c	Gene	54205
38358083	1523	1527	Hhcy	Disease	MESH:D020138
38358083	1603	1608	Abeta	Gene	351
38358083	1655	1659	Hhcy	Disease	MESH:D020138
38358083	1684	1690	VEGF-A	Gene	7422
38358083	1691	1697	VEGFR2	Gene	3791
38358083	1712	1718	VEGFR2	Gene	3791
38358083	1766	1776	angiogenic	Disease	
38358083	1859	1863	Hhcy	Disease	MESH:D020138
38358083	1876	1881	Abeta	Gene	351
38358083	1930	1951	angiogenic impairment	Disease	MESH:D060825
38358083	2006	2017	amyloidosis	Disease	MESH:D000686
38358083	2022	2026	Hhcy	Disease	MESH:D020138
38358083	2060	2074	EC dysfunction	Disease	MESH:D006331
38358083	2079	2084	death	Disease	MESH:D003643
38358083	2170	2172	AD	Disease	MESH:D000544
38358083	2173	2176	CAA	Disease	MESH:C564321
38358083	2181	2185	Hhcy	Disease	MESH:D020138
38358083	Positive_Correlation	MESH:D060825	HGVS:p.E22Q;CorrespondingGene:3126
38358083	Positive_Correlation	MESH:D020138	351
38358083	Positive_Correlation	MESH:D020138	54205
38358083	Association	MESH:D020138	3791
38358083	Positive_Correlation	MESH:D006710	351
38358083	Association	MESH:D006710	MESH:D020138
38358083	Association	MESH:D020138	7422
38358083	Positive_Correlation	MESH:D006710	MESH:D060825
38358083	Association	MESH:D060825	351
38358083	Association	MESH:D060825	3126

